Chuangmei Pharmaceutical (2289.HK) 2021 Interim Results Conference
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments
to post a comment
1